Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

We defined ‘suspected CIDP’ as subjects that fulfilled the required clinical features of CIDP including the typical form, or of any clinical variant except distal CIDP. 13 14 19 Distal CIDP, defined ...

CNW/ - argenx SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Health Canada ...

The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Read more ...

POEMS syndrome remains a diagnostic challenge due to its variable presentation and overlap with other demyelinating neuropathies, such as CIDP. Cases of polyneuropathy, organomegaly, endocrinopathy, ...

VYVGART ® SC is first and only neonatal Fc receptor blocker approved to treat CIDP Authorization is based on global ADHERE study, the largest clinical trial in CIDP to date First novel, targeted ...

The lack of response and bilateral foot drop prompted his physicians to perform genetic testing which confirmed a deletion of PMP22. Hereditary neuropathy with liability to pressure palsies (HNPP) can ...

"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Pipeline Insight, 2025"Growing Market Opportunity Drives Investment in Chronic Inflammatory Demyelinating Polyneuropathy Treatments as Novel ...

Background Patients with anti-MAG neuropathy present with distal demyelinating polyneuropathy, IgM monoclonal gammopathy, and elevated titers of anti-MAG antibodies. Objective This paper reviews what ...

Nerve conduction studies, an invaluable tool in the clinician's "kit", can sometimes lead us astray from the correct diagnosis unless the clinical phenotype is accurately described Until recently, ...